Biotricity Unveils Advanced ePatch Solution, Elevating the Standard for Heart Testing

REDWOOD CITY, Calif. - June 10, 2025 - PRLog -- Biotricity, a leader in medical diagnostic and remote cardiac monitoring technologies, proudly announces the release of its next-generation ePatch—a lightweight, wearable device that's reshaping how clinicians and patients approach the heart test experience.

Engineered to capture comprehensive heart rhythm data over multiple days, the ePatch offers a seamless, wire-free alternative to traditional Holter monitors. By combining long-term ECG monitoring with Biotricity's proven data processing and physician reporting systems, this device enhances diagnostic accuracy for arrhythmias and other cardiac abnormalities.

Redefining the Heart Test

Unlike single-snapshot ECGs, Biotricity's ePatch provides extended monitoring from 24 hours to up to 7 days, ensuring that sporadic irregularities are not missed. This extended observation enables physicians to better detect symptoms like palpitations, dizziness, or unexplained chest discomfort.

Comfortable, Continuous Cardiac Monitoring

Designed with comfort in mind, the ePatch is waterproof, adhesive, and wire-free, allowing patients to go about daily life—including exercise, sleep, and work—without disruption. No external batteries, cables, or recharging is needed, which drastically improves patient compliance and overall test accuracy.

Patients can wear the ePatch discreetly throughout their day, gaining peace of mind while providers receive detailed cardiac data that supports earlier intervention and more targeted care.

About Biotricity
Biotricity (https://biotricity.com/) is a medical technology company focused on delivering innovative, remote biometric monitoring solutions. From the Bioflux® mobile cardiac telemetry system to the latest ePatch technology, Biotricity empowers healthcare providers and patients with tools that make diagnostics more accurate and accessible.